Find out more about our Leukine® Access Program. Click here to get access
A European pharmaceutical company was prioritizing which markets to enter and Thailand ranked as a lower registration priority than other countries.
Thailand remained intriguing because of the initial demand to be served through named-patient access so the pharmaceutical company contacted TannerMAP to see what could be done.
After exploring options, TannerMAP entered into an agreement with the pharmaceutical company to provide exclusive distribution to Thailand.
TannerMAP would not only meet the existing named-patient demand, but the pharmaceutical company would also gain critical insights that it otherwise would not have had:
Do you have a similar unmet need?
1808 Associates Lane
Charlotte, NC 28217
See all Locations
© Tanner Pharma Group; A Bourne Partners Company